Remove FDA Remove Healthcare Provider Remove Patients
article thumbnail

FDA drops PreCert report, new digital health guidances

pharmaphorum

The US FDA’s Center for Devices and Radiological Health (CDRH) dropped a bevy of new digital health guidances and reports today and yesterday, providing some long-awaited clarity and peeks into the agency’s future plans. . The push started yesterday with the 31-page key findings report from the FDA Pre-Certification Program pilot.

FDA 135
article thumbnail

What Pear Therapeutics’ Bankruptcy Has Left the DTX Industry to Ponder

MedCity News

The goal was simple: provide access and focused support to patients remotely while simultaneously relieving overtaxed healthcare facilities. Combined, DTx and DCTs improve patient recruitment, retention, and access, allowing researchers to pull from underserved communities, including rural populations.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

US FDA approves Blueprint Medicines’ indolent systemic mastocytosis therapy

Pharmaceutical Technology

The US Food and Drug Administration (FDA) has granted approval for Blueprint Medicines’ Ayvakit (avapritinib) as the first and only treatment for indolent systemic mastocytosis (ISM) in adult patients. In addition, Ayvakit is the only treatment approved across the spectrum of indolent and advanced systemic mastocytosis.

article thumbnail

Our healthcare has failed us

World of DTC Marketing

IN SUMMARY: American healthcare is failing. Not only has the FDA become a political pawn but almost half the population is now obese. While there are lots of reasons for this the silence of healthcare providers is a huge reason. We need to do to obesity what we did for smoking.

article thumbnail

Pharmaceutical Advertising: Strategies and Insights for Effective Pharma Marketing

Pharma Marketing Network

Understanding Your Audience: Different audiencespatients, healthcare professionals, or payersrequire tailored messages. For instance, while patients prioritize benefits and side effects, healthcare providers look for clinical evidence and efficacy. How can you ensure your strategy stands out?

article thumbnail

10 Innovative Trends in Pharma Marketing: Strategies for Industry Success in 2025

Pharma Marketing Network

As we approach 2025, emerging trends are reshaping how the industry engages with patients and healthcare providers. With advancements in technology, increasing competition, and changing patient expectations, pharma marketers need to stay ahead of the curve. Patient-Centric Marketing Patients want to feel heard.

article thumbnail

Harnessing Marketing Networks in the Pharmaceutical Industry: Strategies for Success

Pharma Marketing Network

These networksspanning healthcare professionals, patients, and digital platformsare the lifeblood of modern pharma marketing. In the pharmaceutical industry, these networks often include healthcare providers, patient groups, digital channels, and key opinion leaders (KOLs). What Are Marketing Networks?